Edwards Lifesciences Corp - Common Stock (EW) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class: Equity / Common Stock
Symbol: EW on NYSE
Shares outstanding: 590,231,680
Price per share: $81.86
All holders as of 31 Dec 2025: Q4 2025
Total 13F shares: 502,102,558
Total reported value: $42,805,108,094
% of total 13F portfolios: 0.02%
Share change: +12,841,988
Value change: +$1,129,064,515
Number of holders: 1,285
Price from insider filings: $81.86

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Edwards Lifesciences Corp - Common Stock (EW) based on Schedule 13D/G filings

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
VANGUARD GROUP INC	12%	$5,273,358,601	69,131,602	The Vanguard Group	31 Dec 2024
BlackRock, Inc.	7.5%	$3,442,673,832	44,267,376	BlackRock, Inc.	30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP	3.4%	$1,547,456,998	19,826,483	Wellington Management Group LLP	30 Jun 2025

As of 31 Dec 2025, 1,285 institutional investors reported holding 502,102,558 shares of Edwards Lifesciences Corp - Common Stock (EW). This represents 85% of the company’s total 590,231,680 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Edwards Lifesciences Corp - Common Stock (EW) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution	Ownership %	Shares Held	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	12%	70,079,435	-0.4%	0.09%	$5,974,271,834
BlackRock, Inc.	8.9%	52,461,915	-3.4%	0.08%	$4,472,378,277
JPMORGAN CHASE & CO	4.4%	26,024,852	+3.9%	0.15%	$2,218,618,661
STATE STREET CORP	4.4%	25,991,524	+1.5%	0.07%	$2,215,777,421
WELLINGTON MANAGEMENT GROUP LLP	3.7%	21,793,949	+4.8%	0.33%	$1,857,934,152
Bank of New York Mellon Corp	3%	17,492,589	-8%	0.26%	$1,491,243,229
FMR LLC	2.8%	16,582,547	+14%	0.07%	$1,413,662,134
JENNISON ASSOCIATES LLC	2.3%	13,780,515	-1.3%	0.71%	$1,174,788,930
GEODE CAPITAL MANAGEMENT, LLC	2.2%	12,784,902	-0.41%	0.07%	$1,084,852,441
NORGES BANK	1.6%	9,427,396		0.09%	$803,685,509
Ninety One UK Ltd	1.3%	7,734,946	-2.2%	1.4%	$659,404,081
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	1.3%	7,732,010	-16%	0.58%	$659,153,842
BROWN ADVISORY INC	1.2%	7,332,126	-0.35%	0.87%	$625,063,738
MORGAN STANLEY	1.2%	7,314,292	+12%	0.04%	$623,543,624
MILLENNIUM MANAGEMENT LLC	1%	6,080,938	+242%	0.37%	$518,399,964
MARSHALL WACE, LLP	1%	5,925,627	+66%	0.49%	$505,159,711
NORTHERN TRUST CORP	1%	5,880,488	-2.7%	0.06%	$501,311,602
DEUTSCHE BANK AG\	0.95%	5,578,796	-9.5%	0.15%	$475,592,359
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	0.91%	5,383,637	-3.6%	0.1%	$458,955,055
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST	0.81%	4,800,000	0%	4.4%	$409,200,000
Legal & General Group Plc	0.75%	4,415,969	+7.5%	0.08%	$376,461,360
NORDEA INVESTMENT MANAGEMENT AB	0.62%	3,642,618	-14%	0.27%	$312,645,903
DIMENSIONAL FUND ADVISORS LP	0.61%	3,600,884	-2.2%	0.06%	$306,996,973
Invesco Ltd.	0.59%	3,461,198	-3.1%	0.05%	$295,067,089
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.58%	3,448,040	-0.15%	0.05%	$293,945,410

Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	502,102,558	$42,805,108,094	+$1,129,064,515	$342,372,525	$260,626,300	$85.25	1,285
2025 Q3	491,155,311	$38,170,223,869	-$828,756,339	$307,819,207	$268,185,534	$77.77	1,246
2025 Q2	501,621,113	$39,209,886,931	+$342,426,537	$110,040,578	$212,699,916	$78.21	1,244
2025 Q1	498,551,233	$36,115,652,063	-$465,368,232	$139,425,123	$197,828,295	$72.48	1,190
2024 Q4	502,121,728	$37,169,453,852	+$1,434,005,846	$224,897,745	$494,200,621	$74.03	1,216
2024 Q3	476,335,956	$31,445,076,186	-$1,421,509,048	$258,117,768	$670,000,381	$65.99	1,173
2024 Q2	490,550,647	$45,304,945,713	+$713,718,504	$243,872,873	$225,333,174	$92.37	1,277
2024 Q1	485,320,749	$46,297,731,358	+$852,078,619	$316,305,851	$369,320,287	$95.56	1,262
2023 Q4	477,829,932	$36,429,234,865	-$1,182,014,878	$165,531,125	$272,784,375	$76.25	1,238
2023 Q3	493,332,184	$34,197,715,244	-$197,281,313	$113,452,983	$223,428,069	$69.28	1,208
2023 Q2	494,404,816	$46,545,398,964	-$181,795,991	$154,633,438	$198,804,528	$94.33	1,271
2023 Q1	496,146,114	$41,039,476,936	-$928,836,476	$124,753,448	$132,170,509	$82.73	1,232
2022 Q4	506,466,540	$37,809,986,212	-$183,554,159	$104,181,917	$138,531,065	$74.61	1,211
2022 Q3	508,531,260	$42,063,615,359	-$189,784,742	$94,858,055	$151,600,000	$82.63	1,228
2022 Q2	508,693,121	$48,384,102,646	+$312,787,497	$113,441,869	$123,268,658	$95.09	1,254
2022 Q1	507,560,223	$59,693,416,781	-$872,591,871	$169,529,000	$207,756,000	$117.72	1,299
2021 Q4	514,695,199	$66,609,194,753	-$186,675,822	$216,080,795	$217,929,305	$129.55	1,305
2021 Q3	513,353,562	$58,112,410,048	+$238,109,088	$198,623,770	$232,064,671	$113.21	1,216
2021 Q2	511,385,312	$52,958,914,663	+$538,462,811	$156,670,410	$279,537,000	$103.57	1,177
2021 Q1	507,991,100	$42,491,394,444	-$423,235,938	$66,632,000	$100,313,000	$83.64	1,126
2020 Q4	513,938,390	$46,860,598,892	+$9,977,557	$123,941,883	$244,804,284	$91.23	1,145
2020 Q3	514,029,273	$41,004,174,710	+$888,569,776	$136,463,984	$203,932,150	$79.82	1,071
2020 Q2	503,046,391	$34,793,459,237	+$22,859,029,603	$140,869,802	$153,585,038	$69.11	1,026
2020 Q1	168,719,752	$31,830,425,940	-$670,882,947	$111,303,000	$152,090,000	$188.62	994
2019 Q4	171,757,851	$40,049,515,897	+$49,626,361	$238,800,000	$229,452,000	$233.29	1,076
2019 Q3	171,570,027	$37,720,644,980	-$179,008,126	$261,860,000	$349,277,000	$219.91	952
2019 Q2	172,806,261	$31,924,084,222	+$289,583,036	$145,168,000	$151,819,000	$184.74	907
2019 Q1	175,225,854	$33,518,122,395	-$302,527,482	$259,197,000	$257,013,000	$191.33	915
2018 Q4	176,822,166	$27,082,266,094	+$78,816,316	$100,745,000	$110,492,000	$153.17	866
2018 Q3	175,353,101	$30,518,436,188	+$110,838,160	$206,275,000	$355,092,000	$174.10	846
2018 Q2	175,078,644	$25,484,757,626	+$115,064,600	$107,997,000	$139,287,000	$145.57	831
2018 Q1	174,088,441	$24,279,007,097	+$51,589,563	$71,085,000	$108,575,000	$139.52	806
2017 Q4	173,971,877	$19,610,101,151	-$379,710,789	$69,163,000	$99,461,000	$112.71	770
2017 Q3	176,631,416	$19,306,929,194	+$151,766,806	$81,109,000	$74,765,000	$109.31	738
2017 Q2	175,996,106	$20,807,081,462	+$123,201,458	$69,744,000	$59,645,000	$118.24	715
2017 Q1	176,531,453	$16,607,495,734	+$771,393,100	$93,177,000	$62,968,000	$94.07	681
2016 Q4	180,450,063	$16,904,815,239	-$153,832,535	$79,627,000	$67,717,000	$93.70	672
2016 Q3	179,768,954	$21,653,083,742	+$145,177,919	$55,300,000	$107,611,000	$120.56	689
2016 Q2	179,067,536	$17,857,436,721	-$88,134,950	$75,946,000	$132,185,000	$99.73	684
2016 Q1	180,474,875	$15,918,030,987	-$228,346,870	$72,520,000	$132,239,000	$88.21	640
2015 Q4	182,680,405	$14,427,556,075	+$7,504,740,825	$31,936,000	$76,282,000	$78.98	594
2015 Q3	87,881,992	$12,493,621,323	+$395,158,469	$32,059,000	$117,459,000	$142.17	560
2015 Q2	85,080,106	$12,117,685,386	-$825,149,875	$27,228,000	$70,682,000	$142.43	573
2015 Q1	90,872,311	$12,937,259,940	-$25,165,926	$23,559,000	$32,832,000	$142.46	567
2014 Q4	91,812,511	$11,696,363,623	-$61,719,579	$38,614,000	$35,742,000	$127.38	551
2014 Q3	92,070,273	$9,405,178,680	-$118,631,518	$20,814,000	$27,112,000	$102.15	484
2014 Q2	93,342,407	$8,012,433,007	-$352,899,046	$34,019,000	$37,991,000	$85.84	421
2014 Q1	97,604,601	$7,243,435,163	-$68,623,352	$53,198,000	$62,856,000	$74.17	402